Evidence map›Paper›PMID 35880821›Full record

SynthesisJournal of hospital medicine2022

Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.

Susan L Calcaterra, Richard Bottner, Marlene Martin, Honora Englander, Zoe M Weinstein, Melissa B Weimer, Eugene Lambert, Matthew V Ronan, Sergio Huerta, Tauheed Zaman and 7 more

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of hospital medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Observational
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 14 institutions in 1 country.

Susan L CalcaterraDepartment of Medicine, Division of General Internal Medicine and Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA.ORCID 0000-0002-0584-7783
Richard BottnerDepartment of Internal Medicine, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0003-4110-1628
Marlene MartinDepartment of Medicine, Division of Hospital Medicine, University of California San Francisco and San Francisco General Hospital, San Francisco, California, USA.ORCID 0000-0001-8727-0289
Honora EnglanderDepartment of Medicine, Section of Addiction Medicine and Division of Hospital Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Zoe M WeinsteinDepartment of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston, Massachusetts, USA.
Melissa B WeimerDepartment of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Eugene LambertDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Matthew V RonanDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-0872-1924
Sergio HuertaDepartment of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
Tauheed ZamanSan Francisco VA Medical Center, San Francisco, California, USA.
Monish UllalDepartment of Internal Medicine at Highland Hospital, Alameda Health System, Oakland, California, USA.
Alyssa F PeterkinDepartment of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston, Massachusetts, USA.
Kristine Torres-LockhartAlbert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
Megan BureshDivision of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-5559-7682
Meghan T O'BrienDepartment of Medicine, Division of Hospital Medicine, University of California San Francisco and San Francisco General Hospital, San Francisco, California, USA.
Hannah SnyderFamily Community Medicine, University of California, San Francisco, San Francisco, California, USA.
Shoshana J HerzigDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0001-8005-4727
Boston University · USHarvard University · USSan Francisco General Hospital · USAlameda Health System · USAlbert Einstein College of Medicine · USBeth Israel Deaconess Medical Center · USBloomberg (United States) · USOregon Health & Science University · USSan Francisco VA Medical Center · USThe University of Texas at Austin · USUniversity of California, San Francisco · USUniversity of Colorado Hospital · USUniversity of New Mexico Hospital · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Western States Node of the National Drug Abuse Treatment Clinical Trials NetworkU10DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCARTY, DENNIS, SORENSEN, JAMES L · 2002 to 2015
$25.2M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Characterizing Opioid-related Adverse Events in Older Adults After Hospital DischargeR01HS026215 · AHRQ · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HERZIG, SHOSHANA J · 2018 to 2022
$1.8M
Understanding Factors that Limit Access to Opioid Use Disorder Treatment in the Hospital to Inform Innovative Approaches to Expand Hospital-Based TreatmentK08DA049905 · NIDA · UNIVERSITY OF COLORADO DENVER · PI CALCATERRA, SUSAN L · 2020 to 2024
$945k
AHRQ HHS R01 HS026215NCATS NIH HHS UL1 TR001863NIDA NIH HHS K08 DA049905NIDA NIH HHS U10 DA015815NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

backgroundHospitalizations related to the consequences of opioid use are rising. National guidelines directing in-hospital opioid use disorder (OUD) management do not exist. OUD treatment guidelines intended for other treatment settings could inform in-hospital OUD management.

objectiveEvaluate the quality and content of existing guidelines for OUD treatment and management. DATA SOURCES: OVID MEDLINE, PubMed, Ovid PsychINFO, EBSCOhost CINHAL, ERCI Guidelines Trust, websites of relevant societies and advocacy organizations, and selected international search engines. STUDY SELECTION: Guidelines published between January 2010 to June 2020 addressing OUD treatment, opioid withdrawal management, opioid overdose prevention, and care transitions among adults. DATA EXTRACTION: We assessed quality using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. DATA SYNTHESIS: Nineteen guidelines met the selection criteria. Most recommendations were based on observational studies or expert consensus. Guidelines recommended the use of nonstigmatizing language among patients with OUD; to assess patients with unhealthy opioid use for OUD using the Diagnostic Statistical Manual of Diseases-5th Edition criteria; use of methadone or buprenorphine to treat OUD and opioid withdrawal; use of multimodal, nonopioid therapy, and when needed, short-acting opioid analgesics in addition to buprenorphine or methadone, for acute pain management; ensuring linkage to ongoing methadone or buprenorphine treatment; referring patients to psychosocial treatment; and ensuring access to naloxone for opioid overdose reversal.

conclusionsIncluded guidelines were informed by studies with various levels of rigor and quality. Future research should systematically study buprenorphine and methadone initiation and titration among people using fentanyl and people with pain, especially during hospitalization.

Indexed as

BuprenorphineOpiate OverdoseOpioid-Related DisordersAdultAnalgesics, OpioidHospitalizationHumansMethadoneAnalgesics, OpioidBuprenorphineMethadone

Identifiers

PMID35880821
PMCPMC9474657
OpenAlexW4288036320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.